SHH:688617
APT Medical Inc. · SHH · Healthcare · CNY · FY for 2024
Figures on this page computed 2026-11-08 13:44 UTC
Last close
n/aCNY
Market data
59.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2024
46.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
32.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
4.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
0.004Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.
Then and now
lens 3 of 9| Fact | 2017 | 2024 | Change |
|---|---|---|---|
| Sales | 153,173,915 | 2,065,801,597 | +1,249% |
| Profit | 34,482,646 | 673,151,718 | +1,852% |
| Free cash flow | -12,351,694 | 93,145,074 | +854% |
| Debt | 1,000,000 | 11,285,992 | +1,029% |
| Shares in issue | 105,125,000 | 141,050,984 | +34.2% |
The same five facts for 2017 and 2024, each read from the year's own filing.
The same five facts for 2017 and 2024, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2017
Sales, 2017153,173,915
- Source
- computed
- Statement
- income
- Fiscal year
- 2017
- Reported in
- CNY
Sales, 20242,065,801,597Computed from the filing for 2024
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
Profit, 201734,482,646
- Source
- computed
- Statement
- income
- Fiscal year
- 2017
- Reported in
- CNY
Profit, 2024673,151,718Computed from the filing for 2024
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
Free cash flow, 2017-12,351,693.6
- Source
- computed
- Statement
- income
- Fiscal year
- 2017
- Reported in
- CNY
Free cash flow, 202493,145,074Computed from the filing for 2024
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
Debt, 20171,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2017
- Reported in
- CNY
Debt, 202411,285,992Computed from the filing for 2024
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY
Shares in issue, 2017105,125,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2017
- Reported in
- CNY
Shares in issue, 2024141,050,984Computed from the filing for 2024
- Source
- computed
- Statement
- income
- Fiscal year
- 2024
- Reported in
- CNY